Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled Pembrolizumab

Overview of attention for article published in Journal of Nuclear Medicine, August 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 2 X users

patent: 8 patents

Readers on

mendeley: 188 Mendeley

So far, Altmetric has seen 8 patents that reference this research output.

Method of determining toxicity of an immunomodulatory drug for use in humans

Grant US-12510548-B2

United States of America

30 Dec 2025

DNA APTAMER HAVING AFFINITY FOR PD-1 PROTEIN AND ITS USE

Application EP-4574978-A1

European Patent Office

25 Jun 2025

Humanized mouse models for assessing immune cell therapy

Grant US-12196744-B2

United States of America

14 Jan 2025

Method of determining toxicity of an immunomodulatory drug for use in humans preliminary…

Grant US-11959926-B2

United States of America

16 Apr 2024

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 4 additional patents.